USD 1.89 Billion
Report ID:
SQMIG35D2309 |
Region:
Global |
Published Date: May, 2025
Pages:
196
|Tables:
116
|Figures:
70
Global Blood Group Typing Market size was valued at USD 1.89 Billion in 2023 and is poised to grow from USD 2.08 Billion in 2024 to USD 4.18 Billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).
Advancements in blood typing technologies, high demand for blood transfusions, launch of initiatives to promote awareness, high incidence of chronic diseases, and expansion of healthcare facilities are augmenting the adoption of blood group typing on a global level.
The growing incidence of chronic diseases, such as cancer and anemia, which often require blood transfusions, is driving the demand for blood group typing. Surging demand for blood transfusions and organ transplantations is a leading factor propelling the blood group typing market growth. Innovations such as polymerase chain reaction (PCR)-based techniques, microarray, and massively parallel sequencing have revolutionized the accuracy and efficiency of blood typing. The rapid expansion of hospitals, clinics, and diagnostic centers in both developed and developing regions is creating a robust demand for blood typing services. The integration of artificial intelligence (AI) and automation in blood typing processes is enhancing the accuracy and speed of diagnostics.
On the contrary, high costs of advanced blood group typing technologies, lack of infrastructure and trained professionals, variability in test results, and ethical and cultural barriers are estimated to limit the global blood group typing market penetration through 2032 and beyond.
What is the Role of AI in Blood group typing?
The adoption of automation and artificial intelligence (AI) is revolutionizing blood group typing by enhancing accuracy, reducing manual errors, and improving efficiency. Automated platforms streamline sample processing, analysis, and reporting, allowing for high-throughput testing in hospital labs and blood banks. AI-powered systems can analyze complex serological data, flag discrepancies, and assist in decision-making. This trend is particularly strong in developed countries where clinical laboratories face pressure to deliver faster results with minimal human intervention. As demand for precision medicine grows, these intelligent systems are becoming critical to delivering safe, timely, and accurate blood compatibility assessments, thus shaping the market’s future.
Market snapshot - 2025-2032
Global Market Size
USD 1.89 Billion
Largest Segment
Reagents & Kits
Fastest Growth
Instruments
Growth Rate
9.1% CAGR
To get more reports on the above market click here to Buy The Report
Global blood group typing market is segmented by product, test type, technique, end user, and region. Based on test type, the market is segmented into ABO tests, antigen typing, antibody screening, cross-matching tests, and HLA typing. Based on product, the market is segmented into instruments and reagents & kits. Based on technique, the market is segmented into serology tests and molecular tests. Based on end user, the market is segmented into hospital-based laboratories and independent laboratories & blood banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The reagents and kits segment is estimated to hold the highest global blood group typing market share going forward. Recurring use of reagents and kits for blood typing tests in hospitals, blood banks, and diagnostic labs is helping this segment hold sway over others. High affordability, ease of use, and widespread applicability in transfusion medicine are also helping this segment lead revenue generation.
On the other hand, the demand for instruments is slated to rise at a robust pace over the coming years. Technological advancements and the rising adoption of automation in clinical laboratories are helping generate new opportunities for market players via this segment.
The serology tests segment is slated to spearhead the global blood group typing market revenue generation potential over the coming years. Standardized use of serology tests in hospitals, blood banks, and emergency care units for routine ABO and Rh typing help it emerge as a dominant technique. Reliable results and high compatibility with manual and automated systems are also promoting the adoption of serology tests on a global level.
Meanwhile, the demand for molecular tests is slated to rise at a notable pace in the long run as per this blood group typing market forecast. High accuracy and ability of molecular tests to detect rare or weak antigens is promoting its adoption. These tests use DNA-based techniques to identify blood group genotypes, making them ideal for complex cases such as prenatal screening, transfusion in chronically transfused patients, and organ transplantation.
To get detailed analysis on other segments, Request For Free Sample Report
Frequent organ transplants high surgical procedure volumes are contributing to the high demand for blood group typing in the North American region. Widespread adoption of advanced molecular typing technologies and automation in laboratories further strengthens the region’s dominance. Moreover, the presence of major market players, academic research institutions, and high awareness levels regarding blood safety contribute to sustained market leadership in North America.
High volume of transfusions, organ transplants, and trauma cases in the country are contributing to the dominance of this country in terms of blood group typing adoption. Presence of key companies such as Bio-Rad Laboratories and Thermo Fisher Scientific who actively invest in molecular diagnostics and automation are also helping United States cement its dominance in this region. High investments in healthcare and personalized medicine R&D are also helping create new business scope going forward.
High emphasis of Canada on driving voluntary blood donations and rigorous screening processes create an opportune setting for blood group typing companies. Collaborations between CBS and Héma-Québec facilitate efficient blood product sharing. Structured approach for blood testing & collection and ongoing public awareness campaigns are predicted to bolster the adoption of blood group typing solutions and services in the long run.
Rising population, increased healthcare spending, and greater awareness of transfusion safety are helping Asia Pacific emerge as the fastest-growing regional market for blood group typing providers. Surge in investments in healthcare infrastructure expansion is also influentially driving up the demand for blood group typing solutions and services. A growing burden of chronic diseases and surgeries necessitating transfusions are helping generate new opportunities for market players focusing on this region.
The aging population of Japan plays a crucial role in influencing the demand for blood group typing. High adoption of molecular diagnostics in the country is also enhancing the accuracy of blood typing solutions. Collaborations between research institutions and healthcare providers foster innovation in diagnostic technologies. Japan's focus on precision medicine also contributes to the increasing importance of accurate blood group typing.
South Korea’s emphasis on preventive healthcare leads to regular health screenings, including blood typing. The integration of artificial intelligence and automation in laboratories enhances the accuracy and efficiency of blood tests. Public awareness campaigns and educational programs promote voluntary blood donations, which in turn positively affects the adoption of blood group typing solutions. Government support for research and development in medical diagnostics fosters innovation in blood typing technologies.
Presence of strong public health systems and high rate of voluntary blood donations are helping promote the demand for blood group typing in Europe. Investments in research, early adoption of molecular diagnostics, and strict EU regulatory frameworks for transfusion safety bolster market maturity. Collaborative healthcare initiatives and growing adoption of personalized medicine are also estimated to offer new business scope for blood group typing companies in the region.
National Health Service (NHS) and its specialized authority, NHS Blood and Transplant (NHSBT) play a crucial role in augmenting the demand for blood group typing in the United Kingdom. Emphasis on voluntary blood donations and public health campaigns maintains a reliable blood supply is also helping steadily bolster the adoption of blood group typing solutions and services. Collaborations between research institutions and healthcare providers foster innovation, which is also estimated to boost blood group typing adoption.
Presence of a well-established healthcare system and stringent regulatory standards are allowing Germany to emerge as a key country for blood group typing providers. High rate of voluntary blood donations, ensure a reliable supply for transfusions in the country. Government initiatives promote research in medical diagnostics, leading to innovations in blood typing technologies. Collaborations between academic institutions and healthcare providers enhance the development and adoption of new diagnostic methods.
Presence of a centralized healthcare system and a strong emphasis on public health are helping influence the demand for blood group typing in France. The country's national blood service ensures standardized practices in blood collection and testing. Regular public awareness campaigns encourage voluntary blood donations, maintaining a steady supply for medical needs. France's commitment to healthcare accessibility and quality contributes to the consistent demand for accurate blood group typing.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Government Initiatives and Public Awareness
Expansion of Healthcare Facilities
Variability in Test Results
Ethical and Cultural Barriers
Request Free Customization of this report to help us to meet your business objectives.
Blood group typing providers should focus on raising more awareness regarding the importance of blood donations and transfusions to maximize their sales potential. Investing in the R&D of novel portable and rapid blood typing solutions is also a key opportunity for companies as per this global blood group typing market analysis.
Use of advanced technologies and techniques to improve efficacy and efficiency of blood group typing procedures is the prime focus of startups. Here are some startups that have the potential to augment the blood group typing industry in the long run.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, growing demand for blood transfusions and high incidence of chronic diseases are anticipated to drive the demand for blood group typing going forward. However, high costs of advanced blood typing and variability in test results are slated to slow down the adoption of blood group typing in the future. North America is slated to spearhead the demand for blood group typing owing to the presence of a developed healthcare infrastructure and adoption of advanced molecular typing technologies. Development of molecular and point of care blood typing solutions are anticipated to be key trends driving the blood group typing industry through 2032 and beyond.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 1.89 Billion |
Market size value in 2032 | USD 4.18 Billion |
Growth Rate | 9.1% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Blood Group Typing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Blood Group Typing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Blood Group Typing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Blood Group Typing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Global Blood Group Typing Market size was valued at USD 1.89 Billion in 2023 and is poised to grow from USD 2.08 Billion in 2024 to USD 4.18 Billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).
Blood group typing providers should focus on raising more awareness regarding the importance of blood donations and transfusions to maximize their sales potential. Investing in the R&D of novel portable and rapid blood typing solutions is also a key opportunity for companies as per this global blood group typing market analysis. 'Quotient Limited (Switzerland)', 'CareDx Inc. (U.S.)', 'Agena Bioscience, Inc. (Mesa Laboratories, Inc.) (U.S.)', 'DIAGAST (U.S.)', 'Illumina, Inc. (U.S.)', 'Grifols, S.A. (Spain)', 'Immucor, Inc. (U.S.)', 'Bio-Rad Laboratories, Inc. (U.S.)', 'Thermo Fisher Scientific Inc. (U.S.)', 'Merck KGaA (Germany)', 'QIAGEN (Netherlands)', 'Beckman Coulter, Inc. (Danaher) (U.S.)', 'QuidelOrtho Corporation (U.S.)'
Governments around the world are implementing policies and programs to promote blood donation and ensure the safety of blood transfusions. These initiatives significantly boost blood group typing market outlook by increasing awareness and accessibility of blood typing services. Public health campaigns and subsidies for blood typing equipment are supporting healthcare facilities in adopting advanced blood typing technologies going forward.
Shift Toward Molecular Blood Typing Techniques: Shift from traditional serological methods to advanced molecular typing techniques is gaining traction around the world. Molecular methods, such as PCR and DNA sequencing, allow for more precise identification of rare and weak blood group antigens. These technologies are especially beneficial in complex cases, such as prenatal testing and multi-transfused patients. They also reduce the risk of alloimmunization and transfusion reactions. Hence, focusing on this blood group typing industry trend is slated to help boost revenue generation potential across the study period.
Why is the Adoption of Blood Group Typing High in North America?
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2309
[email protected]
USA +1 351-333-4748